Turn Therapeutics Inc.
TTRX
$13.75
$1.098.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -502.46% | -447.90% | 114.66% | -53.51% | -277.60% |
| Total Depreciation and Amortization | 0.00% | 2.11% | 3.65% | 9.60% | 0.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,291.13% | 102.77% | -5,689.09% | -19.10% | -85.06% |
| Change in Net Operating Assets | 153.55% | -200.63% | -41.97% | 85.85% | 320.62% |
| Cash from Operations | 43.45% | -38.81% | -99.85% | -17.72% | -67.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.46% | 61.15% | 65.03% | -182.39% | -- |
| Cash from Investing | 52.46% | 61.15% | 65.03% | -182.39% | -100.00% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -66.33% | 434.43% | -72.33% | 115.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 145.04% | 434.43% | -72.33% | 115.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.13% | 211.75% | 2,450.84% | -105.18% | 131.04% |